欢迎来到天天文库
浏览记录
ID:15144708
大小:42.00 KB
页数:14页
时间:2018-08-01
《卡维地洛对多柔比星诱导心肌病大鼠氧化应激的影响》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、卡维地洛对多柔比星诱导心肌病大鼠氧化应激的影响作者:俞捷,王成华,陶艾彬,尹春阳,汪建飞,张国辉【摘要】目的:探讨卡维地洛(carvedilol,CVD)对多柔比星(adriamycin,ADR)致心肌病大鼠氧化应激水平的影响及其可能机制。方法:采用腹腔注射多柔比星建立心肌病大鼠模型,随机分为卡维地洛组和多柔比星组,每组10只。另取正常大鼠10只为正常对照组。卡维地洛组每日给予卡维地洛60mg/kg;多柔比星组、正常对照组每日给予相同体积生理盐水,观察8周。第9周行心脏超声和血流动力学检测,测定心室胶原含量,总抗氧化能力和丙二醛浓度。结
2、果:卡维地洛组与多柔比星组相比,可显著提高左室射血分数(P<0.01);降低心肌胶原容积分数(P<0.01)。与正常对照组相比,多柔比星组总抗氧化能力显著降低(P<0.01),丙二醛浓度显著升高(P<0.01);而与多柔比星组相比,卡维地洛组可显著提升总抗氧化能力(P<0.01),明显降低丙二醛浓度(P<0.05)。结论:卡维地洛能显著改善多柔比星引起的血流动力异常,改善心脏收缩与舒张功能,逆转心肌重塑,可能与其提高心肌抗氧化应激能力有关。【关键词】多柔比星;卡维地洛;氧化应激 [Abstract]
3、Objective:Toinvestigatetheinfluenceof14oxygenstressinratwithadriamycininducedcardiomyopathy,andtointervenewiththethirdgenerationblocker:carvediloltoexploreitspossiblemechanism.Methods:MaleSpragueDawleyratswereadministeredadriamycinintraperitoneallyinjected.Randomlydiv
4、idedintotwogroups(n=10ineachgroup):carvedilolgroup(60mg/kgdaily),adriamycingroupandanothernormalheartcontrolgroup(givinganequivalentvolumeof0.9%salinedaily).After8weeksofremedy,echocardiography,hemodynamicparameters,thevolumetricfractionofcollagenousfibre(CVF)andoxidativ
5、estressincludingtotalantioxidationcapacity(TAOC)andmalondialdehyde(MDA)werestudied.Results:Comparedwithadriamycingroup,carvedilolgroupcansignificantlyimproveleftventricularejectionfraction(P<0.01)anddepressCVFobviously(P<0.01).Comparedwithcontrolgroup,adriamycingr
6、oupcansignificantlydecreasetheactivityofTAOC(P<0.01)andimprovethecontentsofMDAgreatly(P<0.01).TheactivityofTAOCinthecarvedilolgroupwasenhancedsignificantlycomparedwiththatintheadriamycingroup(P<0.01).ThecontentsofMDAinthecarvedilolgroupweredecreasedcomparedwit
7、hthatintheadriamycingroup(P<0.05).Conclusion:Carvedilolcanrelieveadriamycininducedhemodynamicabnormality14evidently,improvecardiacsystolicanddiastolicfunctiongreatlyandreverseventricularremodeling.Thismechanismmaybeconcernedwithitsimprovementtooxygenstress. [Keyword
8、s]adriamycin;carvedilol;oxidativestress 多柔比星(adriamycin,ADR)作为一种有效的蒽环类广谱抗癌药物,被广泛应用于治疗多种恶性肿瘤。然而,其具有严重的心
此文档下载收益归作者所有